Stay updated with breaking news from Published July. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Brexucabtagene autoleucel is safe and effective in real-world patients with relapsed/refractory mantle cell lymphoma, regardless of the presence of high-risk features.
The Contemporary Pediatrics Editor-in-Chief reviews the pharmacological breakthroughs and epidemiological setbacks that defined RSV in 2023.
We review Cask Strength, Story of The Barrel, a history lesson on all things oak barrel related.
Supply and demand issues and rising costs drove some insurers to cut coverage.